X – MPX Bioceutical (Acquired)
MPX Appoints New Chief Financial Officer TORONTO, Jan. 16, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) is pleased to announce the appointment of David McLaren...
MPX Signs Agreement With Israeli Pharmaceutical Company Panaxia for the Production and Marketing of Pharma-Grade Cannabinoid Products TORONTO, Jan. 15, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Company”...
MPX Enters Into Management and Option Agreements With Production Facility and Second Dispensary in Maryland One of only 14 Production Licenses Issued to Process Cannabis in the State of...
MPX Comments on Attorney General Jeff Sessions’s Memo re: Marijuana Enforcement TORONTO, Jan. 04, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) would like...
MPX Bioceutical Announces Beth Stavola Appointed to New Jersey Cannabis Industry Association Board of Trustees TORONTO, Jan. 03, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Company” or “MPX”)...
MPX Closes Oversubscribed Private Placement Offering of $26.5 Million TORONTO, Dec. 22, 2017 (GLOBE NEWSWIRE) — (CSE:MPX) (OTC:MPXEF) MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) is pleased...
MPX Bioceutical Corporation Provides Update on Private Placement TORONTO, Dec. 19, 2017 (GLOBE NEWSWIRE) — MPX Bioceutical Corp. (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) is pleased to provide this...
MPX Enters Into Management & Purchase Option Agreements With LMS Wellness, Benefit LLC in Baltimore Maryland TORONTO, Dec. 12, 2017 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Company” or...
MPX Bioceutical Receives Both Municipal and State Approval for GreenMart of Nevada NLV License Transfer Gives MPX strong presence in a large and growing Las Vegas adult use market...
MPX Bioceutical Corporation Announces $25 Million Private Placement of Units TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF) (the “Company” or “MPX”) announced today that...
MPX Reports Q2 Fiscal 2018 Results Improving Gross Margins and Execution of Expansion Strategy TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) — (CSE: MPX) (OTCQB:MPXEF) MPX Bioceutical Corporation (the “Company”...
Election of Board of Directors Appoint Deloitte LLP as Auditor Appointment of Officers Issuance of Stock Options Entering into Executive Services Agreement with Canadian Capital, LLC TORONTO, Nov. 02,...
BCC Provides Update on Health Canada Licensed Producer Application and Owen Sound Facility Build Out TORONTO, Oct. 26, 2017 (GLOBE NEWSWIRE) — The Canadian Bioceutical Corporation (the “Company” or...
BCC Announces Initial US$10 Million Drawdown on Credit Facility Resignation of Director TORONTO, Oct. 24, 2017 (GLOBE NEWSWIRE) — The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF)...
BCC Announces Annual Meeting Details Refresh Board of Directors Appoint Deloitte LLP as Auditors Name Change to MPX Bioceutical Corporation TORONTO, Oct. 13, 2017 (GLOBE NEWSWIRE) — The Canadian...
BCC Signs Definitive Agreement to Expand Into Second Adult Use Market Acquiring award-winning wholesale cannabis business in Las Vegas, Nevada TORONTO, Oct. 13, 2017 (GLOBE NEWSWIRE) — The Canadian...
BCC Reports Q1 Fiscal 2018 Results TORONTO, Sept. 28, 2017 (GLOBE NEWSWIRE) — The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) reported its financial results for the...
BCC Reports Q4 and Fiscal 2017 Results TORONTO, Sept. 08, 2017 (GLOBE NEWSWIRE) — The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today reported its financial results...
BCC to Enter Into Joint Venture With Israeli Pharmaceutical Company Panaxia Differentiation into high-growth market segment under new “Salus Bio-Pharma” brand JV will launch in Arizona & Massachusetts and,...
BCC and MJardin Enter into Strategic Partnership for U.S. Cannabis Expansion Partnership to expand operational capacity and grow profit margins TORONTO and DENVER, Aug. 10, 2017 (GLOBE NEWSWIRE) — The...
BCC Provides Bi-Weekly Update on Status of Management Cease Trade Order TORONTO, Aug. 09, 2017 (GLOBE NEWSWIRE) — The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) further...
Civilized continued its excellent “C-Suite” series of interviews with leading cannabis industry executives, interviewing Scott Boyes, CEO of The Canadian Bioceutical Corporation (CSE: BCC) (OTC: CBICF), which is rapidly...
With the exception of Aphria (TSX: APH) (OTC: APHQF), which has involvement with medical cannabis operations in Arizona and Florida, and CanniMed (TSX: CMED) (OTC: CMMDF), which is pursuing...
BCC Completes Massachusetts Transaction Supporting cultivation, production and up to three dispensaries, positioning company well for high anticipated demand in adult use state TORONTO, Ontario, June 15, 2017 (GLOBE...
BCC to Expand U.S. Footprint With Arizona and Maryland Acquisitions Accretive Arizona Target Entry into early-stage, populous Maryland market TORONTO, May 17, 2017 (GLOBE NEWSWIRE) — (CSE: BCC) (OTC:...
